Journal of Neuro-Oncology

, Volume 78, Issue 3, pp 277–280

Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial

  • A.M. Omuro
  • J.J. Raizer
  • A. Demopoulos
  • M.G. Malkin
  • L.E. Abrey
Clinical–patient studies
  • 119 Downloads

Summary

Temozolomide (TMZ) has shown modest efficacy in the treatment of recurrent brain metastasis (BM). We designed a new regimen utilizing dose-intensified, protracted course of TMZ in combination with vinorelbine, a lipophilic large-spectrum agent, in an attempt to improve the efficacy of TMZ. This phase I study was conducted to establish the maximum tolerated dose (MTD) of vinorelbine for this combination. Patients with recurrent or progressive BM were eligible. Chemotherapy consisted of 28-day cycles with TMZ (150 mg/m2, days 1–7 and 15–21) and vinorelbine (days one and eight at escalating doses). The starting dose was 15 mg/m2, with increments of 5 mg/m2 for each cohort of 3–6 patients, until MTD was reached (30 mg/m2). A total of 21 patients were enrolled; the median age was 59 (41–77). The primary tumor was lung cancer in 13 patients (NSCLC in 10, SCLC in 3), breast in 6, renal in 1 and endometrial in 1. Vinorelbine dose was 15 mg/m2 in seven patients, 20 mg/m2 in five, 25 mg/m2 in four and 30 mg/m2 in six. Grades 3 and 4 neutropenia developed in six patients, lymphopenia in nine, and thrombocytopenia in six; other toxicities were rare. No dose-limiting toxicity was seen. Out of 18 evaluable patients 2 had a radiographic response (one partial and one minor). Disease was stable in 6 of 18 patients and the median survival was 27 weeks. This regimen was well tolerated and a phase II trial using a dose of 30 mg/m2 of vinorelbine is warranted.

Keywords

Brain metastasis breast cancer chemotherapy clinical trial lung cancer temozolomide vinorelbine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • A.M. Omuro
    • 1
  • J.J. Raizer
    • 1
  • A. Demopoulos
    • 1
  • M.G. Malkin
    • 1
  • L.E. Abrey
    • 1
  1. 1.Department of NeurologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations